ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 185

Distribution of Haemochromatosis Arthropathy. High Ankle and Mid Foot Prevalence; A Diagnostic Clue ?

Patrick Kiely1 and Alex Richardson2, 1Rheumatology Dept, St. Georges Healthcare NHS Trust, London, United Kingdom, 2Rheumatology, St George's Healthcare NHS Trust, London, United Kingdom

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Ankle, diagnosis and hemochromatosis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose . Long delays in diagnosis of haemochromatosis are frequent and lead to an adverse affect on hepatic and cardiac outcome. Arthropathy is a highly prevalent and early feature, which could act as a trigger for diagnosis if sufficiently distinctive. We conducted a survey of patients with haemochromatosis to assess the prevalence and distribution of joint symptoms and their relation to the diagnosis.

Methods . A questionnaire was sent to members of the UK Haemochromatosis Society (~1500) in December 2013. Questions assessed how the diagnosis of haemochromatosis was made; symptoms, duration, the prevalence and distribution of affected joints, and the role of a rheumatologist.

Results . Questionnaires were returned by 470 people with haemochromatosis, 97% white, 53% male. The genotype was C282Y homozygous 52%, C282Y/H63D heterozygous 7%, C282Y/wild type heterozygous 5%, unknown 33%. The diagnosis was made at a mean age of 56 years, following family member screening in 20%, well man/woman screening in 23% and as result of symptoms in 57%. At diagnosis the most frequent symptoms attributed to haemochromatosis were fatigue 65% and joint pain 60% (Fig 1), with a mean duration of 8 years (0-65) and mean Ferritin 1752 mg/L.  The diagnosis was most frequently made by a GP 38%, Haematologist 24%, Gastroenterologist 21.5% and Rheumatologist 7%.

88% of respondents reported joint pain, stiffness or swelling. Joint symptoms preceded the diagnosis of haemochromatosis by more than 5 years in 47%, by more than 1 year in 78.5% and post dated the diagnosis in 14.5%. The most prevalent areas affected were hand or wrist 66%, ankle or mid foot 49%, and knee 44% (Fig 2). In the hands the prevalence of symptoms was 1st CMC 60%, wrist 52%, MCP 47%, PIP 48%, and DIP joints 41%. No formal arthritic diagnosis was given to 45%, OA 29%, haemochromatosis arthropathy 11.5%. Dupuytrens disease was reported by 13% of men and 8% of women. Venesection was reported to have helped joint symptoms in 5%, made no impact in 20% and in 51% new joints had become affected following de ironing. A negative impact on employment from arthropathy was reported by 21%, with 9% losing their job.

Conclusion . In haemochromatosis, joint symptoms are highly prevalent at diagnosis, with the ankle and mid foot involved in 49%. In addition to MCP joint disease, an osteoarthritis-like presentation at a relatively young age in the hind or mid foot might be a distinguishing feature to prompt investigations leading to an earlier diagnosis.  

Figure 1 Symptoms at diagnosis

Figure 2 Distribution of joint symptoms


Disclosure:

P. Kiely,
None;

A. Richardson,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distribution-of-haemochromatosis-arthropathy-high-ankle-and-mid-foot-prevalence-a-diagnostic-clue/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology